Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

NCT07305246 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: SHR-A1811
DRUG: Letrozole
DRUG: TAC/AC-T

Sponsor

First Hospital of China Medical University

Collaborators

[object Object]